Matches in Wikidata for { <http://www.wikidata.org/entity/Q91904653> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q91904653 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q91904653 description "scientific article published on 01 August 2019" @default.
- Q91904653 description "wetenschappelijk artikel" @default.
- Q91904653 description "наукова стаття, опублікована 1 серпня 2019" @default.
- Q91904653 name "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 name "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 type Item @default.
- Q91904653 label "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 label "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 prefLabel "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 prefLabel "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 P1433 Q91904653-C4D60FDF-244B-4C7D-A0E4-FA1E44B9FF5D @default.
- Q91904653 P1476 Q91904653-F9C19484-C06A-46CC-B4AC-93CB8BB7E47E @default.
- Q91904653 P2093 Q91904653-132ADCDF-790C-4040-8E6B-BB77C057C67F @default.
- Q91904653 P2093 Q91904653-20EAC8FC-A74A-4D0A-A4C9-82E1140B4AE4 @default.
- Q91904653 P2093 Q91904653-3289E884-DBC1-4311-BDD5-93D7FE0BCCB5 @default.
- Q91904653 P2093 Q91904653-3923EB6C-6158-4B03-A13C-B8694A8AF981 @default.
- Q91904653 P304 Q91904653-25EB8894-3AEA-44B8-B10B-CAB442EC6BC9 @default.
- Q91904653 P31 Q91904653-2CEC2EC1-7C8B-4641-BD17-4262B756C0B3 @default.
- Q91904653 P356 Q91904653-AE343A48-FAD0-4ABD-9233-1525ED4CB79A @default.
- Q91904653 P433 Q91904653-37A0F080-9003-42CB-9D66-F12AD84F0C61 @default.
- Q91904653 P478 Q91904653-75BA2BD2-2131-4B58-9B30-94ED26C89CE0 @default.
- Q91904653 P577 Q91904653-AE196931-AE8B-49C7-9C69-803241390A92 @default.
- Q91904653 P698 Q91904653-B57BA1D5-2F10-4DDE-A615-DF1D73B377E9 @default.
- Q91904653 P356 S00066-019-01470-5 @default.
- Q91904653 P698 31073701 @default.
- Q91904653 P1433 Q15724604 @default.
- Q91904653 P1476 "[Primary radiotherapy and short androgen deprivation therapy of 18 months may be sufficient in patients with localized prostate cancer with high-risk-factor compared to the standard of 28 to 36 months.]" @default.
- Q91904653 P2093 "Dirk Böhmer" @default.
- Q91904653 P2093 "Felix Sedlmayer" @default.
- Q91904653 P2093 "Frank Wolf" @default.
- Q91904653 P2093 "Thomas Wiegel" @default.
- Q91904653 P304 "764-766" @default.
- Q91904653 P31 Q13442814 @default.
- Q91904653 P356 "10.1007/S00066-019-01470-5" @default.
- Q91904653 P433 "8" @default.
- Q91904653 P478 "195" @default.
- Q91904653 P577 "2019-08-01T00:00:00Z" @default.
- Q91904653 P698 "31073701" @default.